Who
Richard J. Ranieri
Director
Company insider
Files Form 4 as: Director, Xencor; EVP, Human Resources, Dendreon; EVP, HR & Administration, Sepracor Inc /de/; Sr. VP, Human Resources, Neurocrine Biosciences.
In numbers
- Trades disclosed
- 79
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $524K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 19 Jan 2006
- Last trade
- 16 Jun 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $67K5,474 at $12.31 | filing |
| 15 Jun 2026filed 17 Jun 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $67K5,474 at $12.31 | filing |
| 16 Jun 2025filed 16 Jun 2025 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $28K2,993 at $9.22 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —27,372 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —13,686 at $0.00 | filing |
| 27 Sep 2024filed 1 Oct 2024 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $52K2,503 at $20.68 | filing |
| 13 Jun 2024filed 17 Jun 2024 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —11,971 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —5,986 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —10,013 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —5,007 at $0.00 | filing |
| 20 Jun 2023filed 21 Jun 2023 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —10,013 at $0.00 | filing |
| 20 Jun 2023filed 21 Jun 2023 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —5,007 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —21,412 at $0.00 | filing |
| 24 Jun 2021filed 25 Jun 2021 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —9,728 at $0.00 | filing |
| 25 Jun 2020filed 29 Jun 2020 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —13,953 at $0.00 | filing |
| 26 Jun 2019filed 27 Jun 2019 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —12,731 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.